Affentranger Associates appeared to be the Corporate Investor, which was created in 2002. The leading representative office of defined Corporate Investor is situated in the Zu00fcrich. The venture was found in Europe in Switzerland.
Among the most popular portfolio startups of the fund, we may highlight SIRS-Lab, InflaRx. Among the most successful fund investment fields, there are Recycling, Energy. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Affentranger Associates, startups are often financed by bm-t beteiligungsmanagement thu00fcringen. The meaningful sponsors for the fund in investment in the same round are bm-t beteiligungsmanagement thu00fcringen. In the next rounds fund is usually obtained by bm-t beteiligungsmanagement thu00fcringen, Swiss Helvetia Fund, Staidson Hongkong Investment.
The real fund results show that this Corporate Investor is 60 percentage points more often commits exit comparing to other companies. The increased amount of exits for fund were in 2017. Comparing to the other companies, this Affentranger Associates performs on 11 percentage points more the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2006. The fund is constantly included in less than 2 deals per year.
Fund Name | Location |
Altos Venture | Allschwil, Basel-Landschaft, Switzerland |
Beijing Beilu Pharmaceutical | Beijing, Beijing, China |
Brentwood Capital Advisors | Franklin, Tennessee, United States |
Chiesi Ventures | Boston, Massachusetts, United States |
Clifford Chance | England, London, United Kingdom |
CME Ventures | Chicago, Illinois, United States |
Corporate Finance Partners | Frankfurt, Germany, Hessen |
Exor | Croatia, Grad Zagreb, Zagreb |
Hub One | Champagne-Ardenne, France, Tremblay |
Lloyd's Lab | England, London, United Kingdom |
MiraeAsset Financial Group | - |
Mix Capital | - |
Morningstar | Chicago, Illinois, United States |
Nu Horizons Investments | - |
OK Gang Capital | - |
Screen Play, LLC | - |
Shengtong Printing | Beijing, Beijing, China |
Shimizu Corporation | Chiyoda, Japan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
InflaRx | 18 Mar 2009 | Thuringia | |||
InflaRx | 18 Mar 2008 | Jena, Thuringia, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
InflaRx | 18 Mar 2009 | Thuringia | |||
InflaRx | 18 Mar 2008 | Jena, Thuringia, Germany |